Angeles Mecate‐Zambrano

Author

University of Münster ORCID

Also Known As

Angeles Mecate-Zambrano, Angeles Mecate‐Zambrano

Publications

554

Citations

H-Index

Concepts

All Affiliations

University of Münster Institute of Molecular Biology University of Helsinki Max Planck Institute for Molecular Biomedicine Ludwig-Maximilians-Universität München

About

Angeles Mecate‐Zambrano is an author at University of Münster specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	240
2	Immunology	3	3	229
3	Cell Biology	2	2	46
4	Natural Sciences	1	1	152
5	Molecular Biology	1	1	11

Angeles Mecate‐Zambrano

Publications

510

Citations

H-Index

Page 1

	Year	Citations
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine Sebastian Schloer, Linda Brunotte, Jonas Goretzko, Emerging Microbes & Infections ImmunologyPharmacotherapyFiasma GroupAntiviral DrugViral Structural Protein	2020	152
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano, British Journal of Pharmacology	2021	110
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages Katja Hönzke, Benedikt Obermayer, Christin Mache, European Respiratory Journal	2022	58
SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids Yotam Menuchin-Lasowski, André Schreiber, Aarón Lecanda, Stem Cell Reports	2022	54
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro Linda Brunotte, Shuyu Zheng, Angeles Mecate‐Zambrano, Pharmaceutics Drug InteractionMedicineAdenosine KinaseWhereas RemdesivirImmunology	2021	42
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier Aileen Faist, Sebastian Schloer, Angeles Mecate‐Zambrano, Antiviral Research Inflammatory Lung DiseaseLung InflammationImmunologyP38 InhibitorsImmunotherapeutics	2022	35
Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function Amol Patil, Darisuren Anhlan, Verónica Ferrando, Journal of Virology	2021	31
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano,	2020	17
Discrete spatio-temporal regulation of tyrosine phosphorylation directs influenza A virus M1 protein towards its function in virion assembly Angeles Mecate‐Zambrano, Swathi Sukumar, Guiscard Seebohm, PLoS Pathogens Tyrosine PhosphorylationViral ReplicationSignal TransductionMolecular VirologyProtein Folding	2020	11

Page 1